Patent · US Expired

Transdifferentiation of pancreatic acinar cells

US7662768B2 · kind B2 · utility

0Cited by
2References
17Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJan 8, 2003
Grant dateFeb 16, 2010
Priority date
Expiry dateJun 30, 2025

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2501/998
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Pancreatic acinar cells contribute to β-cell neogenesis. Hamsters administered pentadecapeptide of INGAP protein demonstrated a 2-fold increase in the number of extra-islet acinar-associated β-cell clusters resulting in a 2.8-fold increase in the overall extra-islet β cell mass as compared to controls. In mammals acinar-to-β-cell differentiation provides an alternate pathway to β-cell neogenesis; INGAP peptide plays a significant role in this process.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.